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Order parameterGuanylate cyclase-activating protein-2 (GCAP-2) is a retinal Ca2+ sensor protein. It plays a central role in shaping
the photoreceptor light response and in light adaptation through the Ca2+-dependent regulation of the
transmembrane retinal guanylate cyclase (GC). GCAP-2 isN-terminallymyristoylatedand the full activationof the
GC requires this lipid modiﬁcation. The structural and functional role of the N-terminus and particularly of the
myristoyl moiety is currently not well understood. In particular, detailed structural information on the
myristoylated N-terminus in the presence of membranes was not available. Therefore, we studied the structure
and dynamics of a 19 amino acid peptide representing the myristoylated N-terminus of GCAP-2 bound to lipid
membranes by solid-state NMR. 13C isotropic chemical shifts revealed a random coiled secondary structure of the
peptide. Peptide segments up toAla9 interactwith themembrane surface.Order parameters for Cα and side chain
carbons obtained from DIPSHIFT experiments are relatively low, suggesting high mobility of the membrane-
associated peptide. Static 2H solid-state NMRmeasurements show that themyristoyl moiety is fully incorporated
into the lipidmembrane. The parameters of themyristoylmoiety and the DMPC hostmembrane are quite similar.
Furthermore, dynamic parameters (obtained from 2H NMR relaxation rates) of the peptide's myristic acid chain
are also comparable to those of the lipid chains of the host matrix. Therefore, the myristoyl moiety of the N-
terminal peptide of GCAP-2 ﬁlls a similar conformational space as the surrounding phospholipid chains.
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The guanylate cyclase-activating proteins (GCAPs) are neuronal
Ca2+sensors (NCS) and belong to the super family of four EF-hand
Ca2+-binding proteins. A common feature of all NCS proteins is that
their ﬁrst EF-hand is not able to bind Ca2+ due to a conserved
proline residue in the loop region of the EF-hand [1]. In GCAPs all the
remaining EF-hands bind Ca2+ ions. The human genome encodes for
at least three GCAP isoforms (GCAP1-3) [2–6], which are expressed
only in the retina [7]. GCAP-1 and GCAP-2 are present in rod as well
as in cone photoreceptor cells, whereas GCAP-3 is only expressed in
cones [8]. GCAP-1 and GCAP-2 play a central role in light adaptation
during phototransduction through the Ca2+-dependet regulation of
retinal guanylate cyclases (GCs).
GCAP-1 and GCAP-2 undergo a Ca2+-level dependent “activator–
inhibitor” transition. They inhibit both isoforms of the retinal
guanylate cyclase (GC-1 and GC-2) at high Ca2+ concentrations
typical for the dark state and activate them when the Ca2+ level
decreases after phototransduction. Each GCAP is able to activate GC-1
and GC-2, so the individual role of each GCAP isoform is not yet fully
understood [9]. The Ca2+ afﬁnities for GCAP-1 and GCAP-2 are within
the physiological range but only at intracellular concentrations of
Mg2+. Because of the about seven-fold different Ca2+-binding
afﬁnities for the GC activation of GCAP-1 compared to GCAP-2, a
“Ca2+ relay” model, in which both GCAPs would be required to
function over the physiological range of Ca2+ concentration, was
proposed. This joint action would lead to an expanded response
range without losing the sensitivity-based cooperative effect of the
Ca2+binding on the GC regulation [10].
Like most other NCS proteins, GCAPs are N-terminally acylated
[11]. N-terminal fatty acylation is the covalent attachment of a
myristic acid or related fatty acids to the α-amino group of an N-
terminal glycine through an amide bond. N-terminal fatty acylation is
carried out cotranslationally by the myristoyl-CoA/protein N-myris-
toyltransferase (E.C.2.3.1.97), also known as N-terminal myristoyl-
transferase [12–14]. In tissues other than the retina, the proteins are
homogenously acylated by myristic acid; therefore, the lipid mod-
iﬁcation is often referred to as N-terminal myristoylation. However, in
photoreceptor cells modiﬁed proteins are heterogeneously acylated;
for bovine GCAP an amount of 13% lauric acid (12:0), 7% myristic acid
(14:0) and 30% 5-cis-tetradecenoic acid (14:1n-9) and 50% 5-cis,8-cis-
tetradecadienoic acid (14:2n-6) was found [11]. Comparative studies
between myristoylated and nonmyristoylated GCAPs revealed differ-
ences in GCAP-1 and GCAP-2. Whereas myristoylation of GCAP-2 has
no inﬂuence on the afﬁnity for the GC-1, GCAP-1 shows a seven-fold
higher afﬁnity to the GC-1 in the myristoylated state [15].
Even though myristoylation is not required for GC activation, the
myristoylated forms are more effective activators of the GC [16]. In fact,
the structural and functional role of the N-terminus and particularly of
themyristoylmoiety is notwell understood. Themain reason is a lack of
structural information. Currently, the structure of Ca2+-bound non-
myristoylated GCAP-2 (solved by solution NMR spectroscopy) is
available [1], as well as the crystal structure of GCAP-3 [17]. Recently,
the ﬁrst structure of a myristoylated GCAP (Ca2+-bound myristoylated
GCAP-1) was solved by X-ray crystallography and revealed that the
myristoyl moiety is completely buried within the N-terminal domain
and has probably a structure stabilizing function [18]. Recent solution
NMR data in the absence of lipid membranes appear to conﬁrm this
result [19]. But until today there is no structural information about any
GCAP bound to, or at least in the presence of a membrane. That is
because standard techniques for structural investigations like X-ray
crystallography and solution NMR spectroscopy usually fail to resolve
structural information in the membrane environment [20]. By contrast,
solid-stateNMR is capable of resolving structural information at least for
membrane-boundpeptides, as demonstrated for numerous examples in
the past [21–28] or recently for the lipid-modiﬁed Ras peptides [29,30].With the limited set of structural data, the role of the myristoyla-
tion of GCAP remains speculative although a general membrane
association of the protein is described [31]. From the structural
information available so far, three major roles of the myristoylation of
NCSs have been discussed [32]. First, the insertion of the myristoyl
group into the lipid bilayer and its function as a membrane anchor.
Second, an extrusion mechanism that exposes the myristoyl group
upon Ca2+ binding of the protein to either insert into the membrane
or bind to and activate a target effector. Third, a protein structure
stabilizing function of the myristoyl group, which is fully buried in a
hydrophobic pocket of the protein [18].
Clearly, more structural information is required to better under-
stand the role of the myristoyl moiety of the GCAPs in the course of
action of the protein. We have previously studied the structure and
dynamics of the myristoyl lipid modiﬁcation of the GCAP-2 protein
bound to lipid membranes [33]. This study provided a ﬁrst hint that
the myristoyl chain is fully inserted into the membrane showing
similar structure and dynamics as the surrounding phospholipids.
Unfortunately, from this 2H NMR study no information about the N-
terminal amino acids in the direct vicinity of the myristoylation was
available. For one reason, speciﬁc isotopic labeling of proteins with
reasonable yields remains a large challenge in structural biology. On
the other hand, fully 13C/15N-labeled membrane-associated proteins
usually do not provide sufﬁcient resolution and sensitivity for efﬁcient
solid-state NMR structure determination. Therefore, we have decided
to continue our investigation of the structure and dynamics of
membrane bound GCAP-2 using myristoylated N-terminal peptides.
Indeed, in the last 15 years a number of studies have shown that that
studies of lipidated peptides helped in understanding some of the
open questions with regard to membrane binding of proteins via lipid
chains [34–38].
In the current paper, we present our data on the structure and the
dynamics of a 19 amino acid peptide representing the myristoylated
N-terminus of GCAP-2 bound to lipid membranes (DMPC liposomes)
by solid-state NMR. We use a combination of methods to study (i) the
secondary structure of several amino acids in the membrane bound
peptide fragment; (ii) the interaction of the GCAP-2moleculewith the
membrane; (iii) the amplitudes of molecular motions in these
residues; and (iv) the structure and dynamics of the myristoyl moiety
attached to the N-terminal Gly residue.
2. Material and methods
2.1. Materials
The glycerophospholipids 1,2-dimyristoyl-sn-glycero-3-phosphocho-
line (DMPC), 1,2-dimyristoyl-sn-glycero-3-phosphocholine-1,1,2,2-d4-N,
N,N-trimethyl-d9 (DMPC-d13), 1,2-dimyristoyl-d54-sn-glycero-3-phos-
phocholine (DMPC-d54), and 1,2-dimyristoyl-d54-sn-glycero-3-phos-
phocholine-1,1,2,2-d4-N,N,N-trimethyl-d9 (DMPC-d67) were purchased
from Avanti Polar Lipids (Alabaster, AL) and used without further
puriﬁcation.
Four myristoylated peptides with an amino acid sequence identical
to the ﬁrst 19 amino acids of GCAP-2 (myr-GQQFSWEEA EENGAV-
GAAD) were synthesized using standard Fmoc solid phase peptide
synthesis. The labeling pattern of the respective peptides is shown in
Scheme 1.
2.2. Sample preparation
To prepare multilamellar vesicles (MLVs), the phospholipids were
suspended in aqueous buffer solution (50mMHEPES,10 mMNaCl, pH
7.4). After 10 freeze–thaw cycles, the solution was extruded 10 times
through two polycarbonate ﬁlters of 100 nm pore size (Millipore,
Billerica) at 37 °C using a LIPEX thermo stated extruder (Biomem-
branes, Vancouer, BC, Canada) [39]. The peptides were dissolved in the
Scheme 1. N-terminal GCAP-2 peptides and labeling schemes.
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lipid molar ratio of 1:20. After incubation for at least 12 h with freeze–
thaw cycles every 2 h the mixture was ultracentrifuged at 150,000×g
for 50min. The resulting pellet was lyophilized and then rehydrated to
a ﬁnal water concentration of 35 % (w/v) with D2O or deuterium-
depleted water for the 1H and 2H NMR measurements, respectively.
For equilibration, the sample was frozen, thawed, stirred and gently
centrifuged several times. The supernatant from the ultracentrifuga-
tionwas analyzed by standard protein determination assays. From the
difference between the initial GCAP-2 concentration and the peptide
concentration determined after centrifugation, the amount of bound
peptide was determined.
2.3. 13C MAS NMR spectroscopy
All 13C experiments were carried out on a Bruker Avance 750 NMR
spectrometer operating at a resonance frequency of 749.8 MHz for 1H
and 188.5MHz for 13C. 13C cross-polarizationmagic angle spinning (CP
MAS) NMR spectra were acquired at (303±0.1) K using a double
resonance MAS probe equipped with a 4-mm spinning module. The
1H and 13C 90° pulse lengths were 4 and 5 μs, respectively, and a CP
contact time of 700 μs was used. A MAS frequency of (7000±2) Hz
was maintained by the pneumatic control unit. For heteronuclear
decoupling a TPPM15 pulse sequence with radiofrequency ﬁeld
strength of 65 kHz was applied during the detection period [40].
The 13C chemical shifts were externally referenced to the Gly 13CO
signal (176.45 ppm relative to TMS) [41].
Spin diffusion experiments were carried out using the published
pulse sequence [42]. For this experiment, a GCAP-2 molecules with
deuteratedmyristoyl chain and U-13C/15N labeled Gly1, Phe4, Ala9, and
Val15 was bound to a headgroup deuterated DMPC-d13 membrane. In
such a membrane, 1H spin diffusion can only originate from the lipid
chains or glycerol region since the deuterated lipid headgroup or D2O
from the hydration shell are not excited by the ﬁrst pulse on the 1H
channel. A long T2 ﬁlter of 6 ms was applied to relax the single
quantum coherences of the peptide. Spin diffusion times of 0, 50, 100,
200, 400, and 900 ms were probed. Data points were corrected for T1
relaxation and normalized to the 900 ms value.
The 1H–13C heteronuclear correlation (HetCor) spectra [43] were
measured using the same parameters as for 13C CP MAS spectra. 1H
chemical shifts were referenced to the DMPC-glycerine-G2 protons at
5.31 ppm relative to TMS [44]. 13C–13C proton driven spin diffusion
spectra [45] were acquired using a mixing time of 500 ms (all other
parameters as above).
The strength of the 13C–1H dipolar couplings was measured using
the constant time dipolar and chemical shift (DIPSHIFT) pulse
sequence [46]. 1H–1H homonuclear decoupling was achieved by the
MREV-8 sequence [47] using a decoupler ﬁeld of 100 kHz. The MAS
frequency was (5000±2) Hz. All other parameters were identical to
the 13C CPMAS NMRmeasurements. The dipolar-induced signal decay
is periodic with the rotor period, so it was only necessary to acquire
the signal over one rotor period. The resulting spectra were only
Fourier transformed in the direct dimension and the dipolar dephasedsignal for each resolved peak was extracted and simulated to obtain
the dipolar coupling. Simulations were carried out as described in
Hong et al. [48]. Powder averaging was performed in 1° increments for
the α and β Euler angles.
C–H order parameters were determined by dividing the measured
dipolar coupling by the rigid limit value for the C–H dipolar coupling.
The rigid limit values were experimentally obtained from measure-
ments of crystalline amino acid preparations: CH (Ala Cα, 11.5 kHz),
CH2 (Gly Cα, 12.8 kHz), and CH3 (Ala Cβ, 18.0 kHz) [49].
2.4. 2H solid-state NMR
All 2H experiments were carried out on a Bruker Avance 750 NMR
spectrometer operating at a resonance frequency of 115.1 MHz for 2H.
The 2H NMR spectra were acquired at (303±0.1) K with a phase-
cycled quadrupolar echo sequence [50]. The two 3 μs 2H 90° pulses
separated by a 60 μs delay and a recycle delay of 1 s were used. Prior to
dePaking of the 2H NMR spectra of the GCAP-2 peptide with a
deuterated myristoyl moiety, a small isotropic fractionwas subtracted
from the NMR spectrum. The resulting 2H powder spectra were
dePaked using the algorithm of McCabe und Wassall [51]. Smoothed
chain order parameters were calculated according to Laﬂeur et al. [52].
The Pake doublets were assigned to the carbons consecutively
according to their increasing quadrupolar splitting.
The 2H relaxation rates for the decay of Zeeman order (R1Z: spin-
lattice relaxation rate) weremeasured using a phase-cycled inversion-
recovery quadrupolar echo pulse sequence with 13 delays between
1 ms and 2.5 s and a relaxation delay of 2 s. All other parameters were
the same as for recording the 2H NMR spectra.
2.5. 31P NMR
All 31P NMR spectra were measured using a DRX-600 NMR
spectrometer (Bruker, Karlsruhe, Germany) operating at a 31P
resonance frequency of 242.8 MHz using a 5-mm double resonance
solution NMR probe. A Hahn-echo pulse sequence with a 7 μs 90°
pulse, a delay of 50 μs between the pulses, a spectral width of 100 kHz
and a relaxation delay of 2 s were used. Low-power broadband 1H
decouplingwas applied during acquisition. To obtain the chemical shift
anisotropy (Δσ) the resulting spectra were simulated using Mathcad
2001 (MathSoft Engeneering and Education, Cambridge, MA).
3. Results
3.1. 31P NMR spectroscopy
To conﬁrm that the phospholipid membranes were in the liquid
crystalline phase and that membrane binding of the peptide does not
disturb the bilayer we measured 31P NMR spectra of DMPC-d54 in the
presence and in the absence of GCAP-2 peptides (spectra not shown).
For pure DMPC-d54 MLVs, a value of Δσ= (46.4±1.0) ppm for the
span of the axially symmetric 31P tensor was obtained. In the presence
of GCAP-2 peptides, Δσ remains unchanged (46.8±1.0 ppm).
Fig. 2. Smoothed chain order parameter |SCD(i) | proﬁles for DMPC-d54 liposomes in the
absence (■) and in the presence (▲) of GCAP-2 peptides and for themyristoyl moiety of
GCAP-2 (●) as a function of the chain segment position determined from the 2H NMR
spectra shown in Fig. 1. Note that the myristoyl moiety has a similar order proﬁle
indicating that its packing and dynamics are similar to the lipids of the DMPC host
membrane.
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liquid crystalline phase and the headgroup orientation andmobility of
the DMPC membrane.
3.2. Structure and dynamics of the myristoyl moiety and the surrounding
lipids of the host membrane
We used 2H solid-state NMR to investigate the structure and the
dynamics of the myristoyl moiety of GCAP-2 and the lipids of the
surrounding membrane. As the host membrane, DMPC liposomes
were chosen, this means that the lipid chain of GCAP-2 and the lipid
chains of the membrane of the host matrix were identical. It has been
demonstrated earlier that GCAP-2 shows a stronger binding to DMPC
liposomes compared to mixed lipid membranes [33]. Although DMPC
is not as physiologically relevant as unsaturated mixtures of lipids
with varying headgroups, the 13C NMR measurements of the current
study necessitated the deuteration of the lipids, which is only
available for DMPC.
To examine the inﬂuence of the peptide on the structure and
dynamics of the host membrane, we studied DMPC-d54 multilamellar
liposomes in the absence and presence of GCAP-2 peptides.
Furthermore, we made use of a GCAP-2 peptide with a deuterated
myristoyl moiety incubated with nondeuterated DMPC liposomes to
investigate the myristoyl moiety as well. The measured 2H solid-state
NMR spectra are shown in Fig. 1. All spectra are well resolved showing
the typical superposition of Pake doublets. The spectral width of about
30 kHz is comparable among all three spectra and typical for lipid
chains in a liquid crystalline phase state. Interestingly, the myristoyl
moiety also shows this characteristic NMR spectrum indicating that it
is well incorporated into the DMPC membrane bilayer.
To analyze the spectra in more detail, smoothed order parameter
proﬁles were calculated (Fig. 2). Compared to pure DMPC-d54
liposomes, the order parameters of DMPC-d54 in the presence of
GCAP-2 peptides were slightly lower. Somewhat lower order para-
meters were observed for the myristoyl moiety of the membraneFig. 1. 115.1 MHz 2H NMR powder spectra of (A) DMPC-d54, (B) DMPC-d54 in the
presence of GCAP-2 peptides, and (C) the deuterated myristoyl moiety of the GCAP-2
peptides in DMPC liposomes, recorded at a temperature of 30 °C. The peptide
concentration was 4.8 mol% and the samples contained 35% (w/v) deuterium-depleted
water. A total of 2048,1024, and 10496 transients was acquired for spectra shown in (A),
(B), and (C), respectively.bound GCAP-2 peptide. Whereas the biggest difference was observed
in the middle of the chains, the order parameters are close at the top
and at the bottom of the chains. All these results indicate that the
myristoyl moiety is incorporated into the membrane bilayer and that
the packing and the dynamics of these chains are rather similar to the
surrounding lipids of the DMPC host membrane.
From the smoothed order parameter proﬁles the lengths (LC⁎) of
the myristoyl chains were calculated using the mean-torque model
[53,54]. For the myristoyl moiety of the GCAP-2 peptide incorporated
into the membrane a chain length of 10.4 Å was found. For the DMPC,
the chain length was 10.6 Å in the absence and 10.5 Å in the presence
of GCAP-2 peptides.
We further investigate the dynamics of the lipid chains by
measuring the Zeeman order 2H NMR relaxation rates (R1Z) for each
carbon position. Empirical studies revealed that the relaxation rate
often exhibits a linear dependence on the square of the order
parameter for saturated phospholipid membranes [55]. Fig. 3 shows
such square law plots obtained for DMPC-d54 liposomes in the
presence and in the absence of GCAP-2 peptides as well as for the
myristoyl moiety of GCAP-2. The square law plots are very similar for
DMPC in the absence and presence of GCAP-2. The plot of the
myristoyl moiety of GCAP-2 is also linear but shows a slightly steeper
slope. Altogether, these results indicate that the ﬂexibility of DMPCFig. 3. Relaxation rates R1Z(i) vs. squared order parameters |SCD(i) |2 for DMPC-d54 liposomes
in the absence (■) and in the presence (▲) of GCAP-2 peptides and for the myristoyl
moiety of the peptide (●). The plots indicate that the ﬂexibility of DMPC lipids is not
inﬂuenced by the peptides; however, the myristoyl moiety of the membrane bound
GCAP-2 peptide is slightly more ﬂexible.
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of the membrane bound GCAP-2 peptide is slightly more ﬂexible.Fig. 5. Contour plot of a 1H–13C heteronuclear correlation spectrum of GCAP-2 peptide
(myr-GQQFSWEEAEENGAVGAAD) bound to DMPC-d67 liposomes, measured at 30 °C,
with a MAS frequency of 7 kHz. No homonuclear decoupling was applied during the
evolution of the 1H chemical shift. The samples contained 35 % (w/v) D2O. A total of 488
transients was acquired in each t1 increment.3.3. The secondary structure of membrane bound N-terminal
GCAP-2 peptide
The 13C isotropic chemical shift of Cα and Cβ atoms, especially the
reference-independent difference Cα–Cβ is a sensitive marker for the
secondary structure [56,57]. So we investigated the secondary
structure of membrane bound GCAP-2 peptides by measuring the
13C CPMASNMR spectra as shown in Fig. 4. These spectrawere excited
via cross-polarization. Due to the choice of labeled amino acids, the
assignment of the resolved peaks in the spectra could be done on the
basis of literature values [58].
To conﬁrm the assignments of the 13C NMR signals and to also obtain
the structurally relevant peak assignment of the Hα signals, 1H–13C
HetCor experimentswere carriedout. A representativeHetCor spectrum
recorded without any homonuclear decoupling during the evolution of
the 1H chemical shift is shown in Fig. 5. Additionally, the assignment of
the Ser5Cα and Glu10Cα signals in Fig. 4Awere checked by a 2D 13C–13C
proton driven spin diffusion experiment (data not sown).
We studied the secondary structure of 10 amino acids of the GCAP-
2 peptide scattered over the entire sequence. Table 1 summarizes the
measured isotropic Hα, Cα, and Cβ chemical shifts and presents the
predicted secondary structure. All chemical shifts are in agreement
with random coil conformation of the membrane-associated peptide.
With the only exception of Ser5 Cα, we have not found any evidenceFig. 4. Proton decoupled 188.5 MHz 13C CP MAS NMR spectra of GCAP-2 peptides bound to D
lipid molar ratio was 1:20. The samples contained 35 % (w/v) D2O. Peptide signals are assign
also assigned. The peptide sequence and labeling schemes are also given. 13C labeled amino
NMR spectrum was 2048, 3072, and 1024 for A–C, respectively.for eitherα-helical or β-sheet conformation. Although not all residues
in the sequence were subjected to the secondary structure analysis,
the maximum information gap amounted to three consecutive
residues. This is too little to assume that a secondary structure
element was formed. Therefore, it is safe to conclude that the entire
membrane-associated peptide assumed a random coil conformation.MPC-d67 membranes, acquired at 30 °C, with a MAS frequency of 7 kHz. The peptide to
ed using the three letter code. Lipid signals that were not or insufﬁciently deuterated are
acids were underlined and highlighted in bold letters. The number of scans for each 13C
Fig. 6. Spin diffusion build-up curves as a function of mixing time (tm) for Gly1Cα (■),
Phe4Cα (♦) and Ala9Cα (●), of the GCAP-2 peptide bound to DMPC-d13 membranes.
Error bars represent the noise level in the 13C spin diffusion spectra.
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After establishing that membrane-associated GCAP-2 peptides
assume a random coil structure in the membrane, we investigated
whether the polypeptide chain was associated with the membrane or
freely mobile in the aqueous phase. To this end, we used an
experiment that exploits spin diffusion that originates in the lipid
membrane and proceeds into the membrane-associated peptide [42].
A myristoylated GCAP-2 peptide was synthesized that featured 13C
isotopic labels at Gly1, Phe4, Ala9, and Val15 and a deuterated myristoyl
moiety. To ensure that 1H spin diffusion would originate from the
glycerol/phospholipid chains, we studied the peptide in a DMPC-d13
membrane, which is deuterated in the headgroup, in the presence of
D2O. Spin diffusion build-up curves from the membrane into the
peptide as a function of mixing time are shown in Fig. 6. For Val15, no
intensity could be detected within experimental error, suggesting that
the C-terminal part of the peptide is not in contact with the
membrane. For the other labels (Gly1, Phe4, Ala9), spin diffusion
build up is detected indicating that these residues are in contact with
the membrane interface region. Within experimental error, these spin
diffusion build-up curves are rather similar suggesting that the amino
acids up to residue 9 are in contact with the membrane. Given the
quality of the experimental data, a more quantitative analysis of the
spin diffusion results was not possible. As seen from Fig. 6, the built up
has not reached a plateau value after 900 ms. As suggested from the
good resolution of the 1H–13C HetCor experiments, the lipidated
peptide is rather mobile on the membrane surface, which decreases
the spin diffusion efﬁciency. Furthermore, molecular mobility reduces
the efﬁciency of the short CP or Lee-Goldburg-CP, respectively. A
relatively long T2 ﬁlter time of 6 ms had to be used to fully relax the
magnetization of the peptide, which further decreased the sensitivity
of the experiment.
In spite of these technical difﬁculties, which prevented a
quantitative analysis of the spin diffusion experiment, the interesting
result emerged that the peptide segments at least up to Ala9 must be
in contact to the lipid membrane interfacewhile the second half of the
peptide is more localized in the aqueous phase.
3.5. Dynamics of membrane bound GCAP-2 peptides
The previous experiments suggested a high mobility of the
membrane-associated GCAP-2 peptide. Therefore, we quantitatively
studied the dynamics of themolecule at themembrane to gain further
insight into the membrane binding of the amino acids adjacent to the
myristoylation.
We used the DIPSHIFT pulse sequence to determine the strength of
the 1H–13C dipolar couplings along the backbone and the side chains
of the membrane bound GCAP-2 peptides. Fast anisotropic molecular
motions partially average these couplings. This allows determining
the spatial restriction of the motions of the C–H bond vectors, whichTable 1
Isotropic chemical shifts for the Cα, Cβ, and Hα atoms (in ppm), difference of the
chemical shifts (Cα–Cβ) and predicted secondary structure.
Cα Cβ Cα–Cβ Hα Secondary structure
Gly1 43.8 ± 0.5 – – 4.1 random coil
Phe4 54.6 ± 0.5 37.1 ± 0.5 17.5 ± 0.5 4.6 random coil
Ser5 55.5 ± 0.1 62.2 ± 0.1 -6.7 ± 0.1 4.4 random coil / β-sheet
Ala9 50.4 ± 0.5 17.5 ± 0.1 32.9 ± 0.5 4.3 random coil
Glu10 54.5 ± 0.1 28.6 ± 0.1 25.9 ± 0.1 4.1 random coil
Gly13 43.3 ± 0.4 – – 4.0 random coil
Ala14 49.9 ± 0.4 17.0 ± 0.4 32.9 ± 0.4 4.4 random coil
Val15 60.6 ± 0.1 30.5 ± 0.3 30.1 ± 0.3 4.1 random coil
Gly16 43.2 ± 0.1 – – 4.1 random coil
Ala18 50.7 ± 0.1 17.4 ± 0.2 33.3 ± 0.2 4.4 random coil
All chemical shifts are measured at a temperature of 30 °C and referenced relative to
TMS.can be expressed by an order parameter S that is deﬁned as the ratio of
the motional averaged and the full dipolar coupling. Fig. 7 shows the
experimental order parameters for the membrane bound GCAP-2
peptide. The order parameters along the polypeptide chain do not
show a conclusive increase or decrease along the polypeptide chain
and are relatively low indicating that the membrane bound peptide
undergoes large-amplitude molecular motions. For the Ala14 Cβ and
Ala18 Cβ no order parameter could be determined because the signal
intensity was too low. Also for Ser5 Cβ, no order parameter could be
obtained because the signal overlapped with the lipid G1 signal.
Furthermore, the Glu10 Cβ signal was inﬂuenced too strongly by the
lipid C4-C11 signal to determine the order parameter correctly.
The order parameters obtained for the Cβ atoms are typically lower
then for the neighboring Cα atoms, which indicates that the
amplitude of motions increases along the side chains. An exception
is the Phe4 Cβ, which has a higher order parameter then its
corresponding Cα site. Interestingly, the ring atoms show very low
order parameters, which could be a result of fast two-site jump
motions.
With the exception of Glu10, the Cα order parameters fall between
∼0.2 and 0.45. This would be in agreement that the entire polypeptide
chain is located in the membrane surface/interface area. It is
conceivable that the charged Glu residues are repelled from theFig. 7. 1H–13C order parameters along the backbone and the side chains of the
membrane bound GCAP-2 peptide. Dark gray bars correspond to order parameters
determined for Cα, light gray bars for Cβ. The sequence is shown above. 13C labeled
amino acids are marked with bold black letters.
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molecular order.
4. Discussion
All members of the NCS protein family are myristoylated, however,
the biological function of these covalently attached groups appears to
vary [32]. Here, we have studied structure, dynamics, and membrane
binding of a myristoylated peptide from the N-terminus of GCAP-2
using solid-state NMR spectroscopy. Although the intramolecular
interactions within the GCAP protein are not represented, the
advantage of using a peptide model is that all measurements could
be carried out in the presence of lipid bilayer membranes, which was
not the case in either the crystal or the solution NMR studies on
GCAPs. While the structure of the soluble protein part would most
likely not be inﬂuenced by membrane binding, an important question
regards the myristoylation and the adjacent residues on the N-
terminus of the protein. Since solution NMR or X-ray methods often
fail for membrane-associated proteins, solid-state NMRwas employed
here. This methodology necessitated the use of shorter peptides for
resolution and sensitivity reasons. Nevertheless, the lipid-modiﬁed
membrane anchor of a protein can be treated rather independently
from the soluble rest of themolecule. This is suggested from structural
data for the Ras protein, which has demonstrated that lipidated
peptides representing the membrane anchor of the molecule exhibit
akin structural and dynamic features compared to the entire
membrane-associated Ras protein [30,34]. In particular, our data on
the structure and dynamics of the myristoylation of the GCAP-2
peptide show a very similar structure and dynamics as found for the
full-length protein [33], which suggests that the results from the
peptide model of the current study have relevance for the GCAP-2
protein. With this prerequisite we continued to study structure,
membrane topology, and dynamics of the amino acids adjacent to the
myristoylation of GCAP-2 in the membrane.
First, we investigated the secondary structure of a membrane bound
N-terminal peptide of GCAP-2 (amino acids 1–19) by measuring the
isotropic chemical shifts of the Hα, Cα, and Cβ atoms. Although the
solution NMR structure of non-myristoylated GCAP-2 solved by Ames
et al. [1], shows a shortα-helix in theN-terminal region (residues 7–11),
we could not conﬁrm any secondary structure in theN-terminal peptide
of membrane bound GCAP-2 peptides. All measured 13C chemical shifts
predict a random coil conformation. Possibly, theα-helix is only formed
when interactionswith the rest of the protein occur or is induced by the
solution condition in the absence ofmembranes. But strong interactions
between the N-terminus of GCAP-2 and the rest of the protein seem to
be unlikely considering the high ﬂexibility of this protein segment
shown in the solution NMR data [1]. Furthermore, the short α-helix in
the N-terminal segment is not compatible withmembrane binding. The
amino acid sequence of this helix is Trp-Glu-Glu-Ala-Glu. In a helical
wheel presentation, the negatively charged amino acids would point
into all directions rendering the helix very hydrophilic. Such a helix can
not bind to the membrane surface. Born repulsion between the ﬁxed
charges on the Glu residues and themembrane surface of low dielectric
constant would repel this structural arrangement from the membrane
[59].
Second, the spin diffusion experiments conducted here suggest
that the polypeptide chain at least until Ala9 interacts with the
membrane interface. This is in agreement with the absence of the
short α-helix in the N-terminus of GCAP-2. Apparently, the myr-
istoylation togetherwith the hydrophobic sidechains (Phe, Trp) tie the
peptide to the membrane surface where hydrogen bonds between the
peptide backbone and the carbonyl and phosphate groups of the lipid
molecules can be formed. In such a structural arrangement, the
negatively charged sidechains of the Glu residues can point away from
the membrane minimizing the energy penalty arising from Born
repulsion. Typically, nonhydrogen bonded polypeptides cannot crossthe membrane [60], but the localization at the surface or in the lipid–
water interface of the membrane offers various ways of interaction
with polar and apolar lipid segments as well as hydrogen bond
formation with the carbonyl and phosphate groups from the lipids.
Such interactions can generate sufﬁcient free energy for such a
structural arrangement.
Third, we studied the molecular dynamics of the membrane-
associated GCAP-2 peptide. Thesemolecules are highly dynamic in the
membrane environment as shown by the low order parameters. This
high mobility expressed by low order parameters are also in
agreement with a random coil conformation of the peptide and can
explain the good resolution in the 1H dimension of the 1H–13C HetCor
experiments. Due to the high mobility, the dipolar couplings that
broaden the 1H NMR spectra are reduced and could efﬁciently average
out by MAS. Low order parameters, i.e., high mobility was also found
for the membrane-associated Ras protein, although this molecule
features two lipid modiﬁcations [29,61]. Apparently, membrane
binding through covalently attached lipid chains also renders the
peptide chain rather mobile as is the liquid crystalline lipid
membrane.
Fourth, we investigated the structure and the dynamics of the
myristoyl moiety of themembrane bound GCAP-2 peptide. Our results
show that the myristoyl chain of the peptide is fully incorporated into
the phospholipid bilayer, whereas the order parameter, the chain
length, and the square law plot are comparable to the lipid chains of
the DMPC host matrix. This conﬁrms previous studies on the full-
length GCAP-2 protein [33]. This result alsomeans that the N-terminal
peptide segment is placed into the lipid water interface of the
membrane, which is conﬁrmed by our spin diffusion studies. This
situation is for example also found in the Ras peptide [34]. None-
theless, the lipid modiﬁcations of Ras were found to be more mobile
than the lipid chains of the host matrix as a consequence of the chain
length adaptation to the host membrane [54]. For the GCAP-2 peptide
with its myristoyl moiety and a DMPC host matrix, there is no need for
a largely alteredmobility of themyristoyl moiety tomatch the average
length of the host matrix. Consequently, we found that the mobility of
the myristoyl moiety is comparable to the mobility of the DMPC lipid
chains. Furthermore, all determined parameters concerning the
structure and the dynamics of the myristoyl moiety of the peptide
are in agreement with those for the myristoyl moiety of the whole
GCAP-2 protein in DMPC membranes [33].
Former studies on lipid modiﬁed peptides revealed that each
methylene group of the lipid chain that partitions into a lipid
membrane contributes −3.45 kJ/mol to the Gibbs free energy of the
membrane binding [62]. The unitary Gibbs free energy for partitioning
a lipid acid chain into n-heptane can be estimated byΔG0u= (17.81−
3.45 nC) kJ/mol and also includes a term for the enthalpy penalty
(17.81 kJ/mol) [62]. Using this model, for the myristic acid on the
GCAP-2 peptide, a Gibbs free energy for membrane partitioning of
∼−27 kJ/mol arises. Together with the contribution from the highly
hydrophobic Phe and Trp residues, a favorable free energy for
membrane binding of ΔG0u ≈-40 kJ/mol is estimated. Following the
simple model used by Vogel et al. [33] to understand the contribution
of themyristoylmoiety to themembrane binding of thewhole GCAP-2
protein, a Gibbs free energy of ∼-40 kJ/mol results in ∼90% bound
peptide. Routinely, we determined the fraction of DMPC-bound
peptide in a centrifugation assay. Typically, about 75% of GCAP-2 was
membrane bound under the conditions used in our experiments (data
not shown). In good agreement with this crude thermodynamic
estimation, the myristoyl moiety is inserted into the membrane and
the Gibbs free energy of this insertion can fully explain the peptide
binding to the membrane. This may also suggest that the hydrophobic
residues Phe4 and Trp6 are not permanently membrane inserted,
which also agrees with the highmobility we found for Phe4. Therefore,
the myristoyl moiety should play an important role in membrane
binding at least for the peptide.
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[33] show that the myristoylation of GCAP-2 is inserted into the
membrane. This would agree with the function of that chain as a
membrane anchor. Interestingly, former biochemical and biophysical
studies have shown that the myristoyl moiety is important for the
activation of the GC, but is not essential for membrane binding [16],
which would support a model, where the myristic acid chain switches
between amembrane and a protein imbedded state (“switchmodel”).
At this point, it must remain open if the myristoylation of GCAP-2 may
be extracted from the membrane to play a role in the activation of the
GC. Clearly, interaction studies of GCAP-2 with the GC will shed light
on this important issue but our work suggests that the myristoylation
of GCAP-2 represents an essential contribution of the membrane
binding energy of the protein. It is also possible, that the myristoyl
moiety of GCAP-2 may direct the protein to the right membrane
compartment. Clearly, interaction studies between GCAP proteins and
peptides with the GC or segments of this protein are necessary to fully
understand the role of the myristoyl moiety of the GCAPs. These
studies represent the next steps in our activity in this ﬁeld.
Acknowledgements
This work was supported by the Deutsche Forschungsge-
meinschaft (DFG, HU 720/10-1) and the “Exzellenznetzwerk Biowis-
senschaften” funded by the federal state of Sachsen-Anhalt. We also
thank the DFG and the Experimental Physics Institutes of the
University of Leipzig for providing measuring time on the Avance
750 MHz NMR spectrometer. The GCAP peptides were synthesized at
the IZKF core unit of the Medical Faculty at the University of Leipzig.
References
[1] J.B. Ames, A.M. Dizhoor, M. Ikura, K. Palczewski, L. Stryer, Three-dimensional
structure of guanylyl cyclase activating protein-2, a calcium-sensitive modulator
of photoreceptor guanylyl cyclases, J. Biol. Chem. 274 (1999) 19329–19337.
[2] A.M. Dizhoor, E.V. Olshevskaya, W.J. Henzel, S.C. Wong, J.T. Stults, I. Ankoudinova,
J.B. Hurley, Cloning, sequencing, and expression of A 24-KDa Ca2+-binding protein
activating photoreceptor guanylyl cyclase, J. Biol. Chem. 270 (1995) 25200–25206.
[3] W.A. Gorczyca, A.S. Polans, I.G. Surgucheva, I. Subbaraya, W. Baehr, K. Palczewski,
guanylyl cyclase-activating protein—a calcium-sensitive regulator of phototrans-
duction, J. Biol. Chem. 270 (1995) 22029–22036.
[4] F. Haeseleer, I. Sokal, N. Li, M. Pettenati, N. Rao, D. Bronson, R.Wechter,W. Baehr, K.
Palczewski, Molecular characterization of a third member of the guanylyl cyclase-
activating protein subfamily, J. Biol. Chem. 274 (1999) 6526–6535.
[5] K. Palczewski, I. Subbaraya, W.A. Gorczyca, B.S. Helekar, C.C. Ruiz, H. Ohguro, J.
Huang, X.Y. Zhao, J.W. Crabb, R.S. Johnson, K.A. Walsh, M.P. Gray-Keller, P.B.
Detwiler, W. Baehr, Molecular-cloning and characterization of retinal photo-
receptor guanylyl cyclase-activating protein, Neuron 13 (1994) 395–404.
[6] W.A. Gorczyca, M.P. Gray-Keller, P.B. Detwiler, K. Palczewski, Puriﬁcation and
physiological evaluation of a guanylate cyclase activating protein from retinal
rods, Proc. Natl. Acad. Sci. U. S. A. 91 (1994) 4014–4018.
[7] R.D. Burgoyne, J.L. Weiss, The neuronal calcium sensor family of Ca2+-binding
proteins, Biochem. J. 353 (2001) 1–12.
[8] Y. Imanishi, G. Li, I. Sokal, M.E. Sowa, O. Lichtarge, T.G. Wensel, D.A. Saperstein, W.
Baehr, K. Palczewski, Characterization of retinal guanylate cyclase-activating
protein 3 (GCAP3) from zebraﬁsh to man, Eur. J. Neurosci. 15 (2002) 63–78.
[9] R. Stephen, S. Filipek, K. Palczewski, M.C. Sousa, Ca2+-dependent regulation of
phototransduction, Photochem. Photobiol. 84 (2008) 903–910.
[10] K.W. Koch, GCAPs, the classical neuronal calcium sensors in the retina. A Ca2+-
relay model of guanylate cyclase activation, Calcium Binding Proteins 1 (2006)
3–6.
[11] J.C. Demar, D.R. Rundle, T.G. Wensel, R.E. Anderson, Heterogeneous N-terminal
acylation of retinal proteins, Prog. Lipid Res. 38 (1999) 49–90.
[12] R.J. Duronio, D.A. Towler, R.O. Heuckeroth, J.I. Gordon, Disruption of the yeast N-
myristoyl transferase gene causes recessive lethality, Science 243 (1989) 796–800.
[13] C.J. Glover, C. Goddard, R.L. Felsted, N-myristoylation of p60src. Identiﬁcation of a
myristoyl-CoA:glycylpeptide N-myristoyltransferase in rat tissues, Biochem. J. 250
(1988) 485–491.
[14] D.A. Towler, S.P. Adams, S.R. Eubanks, D.S. Towery, E. Jacksonmachelski, L.
Glaser, J.I. Gordon, Puriﬁcation and characterization of yeast myristoyl-CoA-
protein N-myristoyltransferase, Proc. Natl. Acad. Sci. U. S. A. 84 (1987)
2708–2712.
[15] J.Y. Hwang, K.W. Koch, The myristoylation of the neuronal Ca2+-sensors guanylate
cyclase-activating protein 1 and 2, Biochim. Biophys. Acta 1600 (2002) 111–117.
[16] E.V. Olshevskaya, R.E. Hughes, J.B. Hurley, A.M. Dizhoor, Calcium binding, but not a
calcium-myristoyl switch, controls the ability of guanylyl cyclase-activatingprotein GCAP-2 to regulate photoreceptor guanylyl cyclase, J. Biol. Chem. 272
(1997) 14327–14333.
[17] R. Stephen, K. Paiczewski, M.C. Sousa, The crystal structure of GCAP3 suggests
molecular mechanism of GCAP-linked cone dystrophies, J. Mol. Biol. 359 (2006)
266–275.
[18] R. Stephen, G. Bereta, M. Golczak, K. Palczewski, M.C. Sousa, Stabilizing function
for myristoyl group revealed by the crystal structure of a neuronal calcium sensor,
guanylate cyclase-activating protein 1, Structure 15 (2007) 1392–1402.
[19] S. Lim, I. Peshenko, A. Dizhoor, J.B. Ames, Effects of Ca2+, Mg2+, andmyristoylation
on guanylyl cyclase activating protein 1 structure and stability, Biochemistry 48
(2009) 850–862.
[20] J. Torres, T.J. Stevens, M. Samso, Membrane proteins: the ‘Wild West’ of structural
biology, Trends Biochem. Sci. 28 (2003) 137–144.
[21] D. Huster, Investigations of the structure and dynamics of membrane-associated
peptides by magic angle spinning NMR, Prog. Nucl. Magn. Reson. Spectrosc. 46
(2005) 79–107.
[22] T.A. Cross, S.J. Opella, Solid-state NMR structural studies of peptides and proteins
in membranes, Curr. Opin. Struct. Biol. 5 (1994) 574–581.
[23] J.H. Davis, M. Auger, Static and magic angle spinning NMR of membrane peptides
and proteins, Prog. Nucl. Magn. Reson. Spectrosc. 35 (1999) 1–84.
[24] E. Strandberg, A.S. Ulrich, NMR methods for studying membrane-active
antimicrobial peptides, Concepts Magn. Reson. 23A (2004) 89–120.
[25] B. Bechinger, The structure, dynamics and orientation of antimicrobial peptides
in membranes by multidimensional solid-state NMR spectroscopy, Biochim.
Biophys. Acta 1462 (1999) 157–183.
[26] S. Luca, H. Heise, M. Baldus, High-resolution solid-state NMR applied to
polypeptides and membrane proteins, Acc. Chem. Res. 36 (2003) 858–865.
[27] G. Lindblom, G. Grobner, NMR on lipid membranes and their proteins, Curr. Opin.
Coll. Int. Sci. 11 (2006) 24–29.
[28] M. Hong, Structure, topology, and dynamics of membrane peptides and proteins
from solid-state NMR Spectroscopy, J. Phys. Chem. B 111 (2007) 10340–10351.
[29] L. Brunsveld, H. Waldmann, D. Huster, Membrane binding of lipidated Ras
peptides and proteins — The structural point of view, Biochim. Biophys. Acta 1788
(2009) 273–288.
[30] G. Reuther, K.T. Tan, J. Köhler, C. Nowak, A. Pampel, K. Arnold, J. Kuhlmann, H.
Waldmann, D. Huster, Structural model of the membrane-bound C terminus of
lipid-modiﬁed human N-ras protein, Angew. Chem. Int. Ed Engl. 45 (2006)
5387–5390.
[31] T.G. Wensel, Signal transducing membrane complexes of photoreceptor outer
segments, Vision Res. 48 (2008) 2052–2061.
[32] L.P. Haynes, R.D. Burgoyne, Unexpected tails of a Ca2+sensor, Nat. Chem. Biol. 4
(2008) 90–91.
[33] A. Vogel, T. Schroder, C. Lange, D. Huster, Characterization of the myristoyl lipid
modiﬁcation of membrane-bound GCAP-2 by H-2 solid-state NMR spectroscopy,
Biochim. Biophys. Acta 1768 (2007) 3171–3181.
[34] D. Huster, A. Vogel, C. Katzka, H.A. Scheidt, H. Binder, S. Dante, T. Gutberlet, O.
Zschörnig, H. Waldmann, K. Arnold, Membrane insertion of a lipidated ras peptide
studied by FTIR, solid-state NMR, and neutron diffraction spectroscopy, J. Am.
Chem. Soc. 125 (2003) 4070–4079.
[35] R.M. Peitzsch, S. McLaughlin, Binding of acylated peptides and fatty acids to
phospholipid vesicles: pertinence to myristoylated proteins, Biochemistry 32
(1993) 10436–10443.
[36] C.T. Pool, T.E. Thompson, Chain length and temperature dependence of the
reversible association of model acylated proteins with lipid bilayers, Biochemistry
37 (1998) 10246–10255.
[37] S. Shahinian, J.R. Silvius, Doubly-lipid-modiﬁed protein sequence motifs exhibit
long-lived anchorage to lipid bilayer membranes, Biochemistry 34 (1995)
3813–3822.
[38] H.A. Scheidt, D. Huster, Structure and dynamics of the myristoyl lipid modiﬁcation
of Src peptides determined by 2H solid-state NMR Spectroscopy, Biophys. J. 96
(2009) 3663–3672.
[39] M.J. Hope, M.B. Bally, G. Webb, P.R. Cullis, Production of large unilamellar vesicles
by a rapid extrusion procedure. Characterization of size distribution, trapped
volume, and ability to maintain a membrane potential, Biochim. Biophys. Acta 812
(1985) 55–65.
[40] A.E. Bennett, C.M. Rienstra, M. Auger, K.V. Lakshmi, R.G. Grifﬁn, Heteronuclear
decoupling in rotating solids, J. Chem. Phys. 103 (1995) 6951–6958.
[41] C.R. Morcombe, K.W. Zilm, Chemical shift referencing in MAS solid state NMR,
J. Magn. Reson. 162 (2003) 479–486.
[42] D. Huster, X. Yao, M. Hong, Membrane protein topology probed by 1H spin
diffusion from lipids using solid-state NMR spectroscopy, J. Am. Chem. Soc. 124
(2002) 874–883.
[43] C.W. Lee, R.G. Grifﬁn, Two-dimensional 1H/13C heteronuclear chemical shift
correlation spectroscopy of lipid bilayers, Biophys. J. 55 (1989) 355–358.
[44] D. Huster, K. Arnold, K. Gawrisch, Investigation of lipid organization in biological
membranes by two-dimensional nuclear Overhauser enhancement spectroscopy,
J. Phys. Chem. B 103 (1999) 243–251.
[45] N.M. Szeverenyi, M.J. Sullivan, G.E. Maciel, Observation of spin exchange by two-
dimensional Fourier transform 13C cross polarization magic-angle spinning,
J. Magn. Reson. 47 (1982) 462–475.
[46] M.G. Munowitz, R.G. Grifﬁn, G. Bodenhausen, T.H. Huang, Two-dimensional
rotational spin-echo nuclear magnetic resonance in solids: correlation of
chemical shift and dipolar interactions, J. Am. Chem. Soc. 103 (1981)
2529–2533.
[47] W.K. Rhim, D.D. Elleman, R.W. Vaughan, Enhanced resolution for solid state NMR,
J. Chem. Phys. 58 (1973) 1772–1773.
274 S. Theisgen et al. / Biochimica et Biophysica Acta 1798 (2010) 266–274[48] M. Hong, J.D. Gross, R.G. Grifﬁn, Site-resolved determination of peptide torsion
angleΦ from relative orientations of backbone N–H and C–H bonds by solid-state
NMR, J. Phys. Chem. 101 (1997) 5869–5874.
[49] D. Huster, L. Xiao, M. Hong, Solid-state NMR investigation of the dynamics of
soluble and membrane-bound colicin Ia channel-forming domain, Biochemistry
40 (2001) 7662–7674.
[50] J.H. Davis, K.R. Jeffrey, M. Bloom, M.I. Valic, T.P. Higgs, Quadrupolar echo deuteron
magnetic resonance spectroscopy in ordered hydrocarbon chains, Chem. Phys.
Lett. 42 (1976) 390–394.
[51] M.A. McCabe, S.R. Wassall, Fast-Fourier-transform DePaking, J. Magn. Reson. B 106
(1995) 80–82.
[52] M. Laﬂeur, B. Fine, E. Sternin, P.R. Cullis, M. Bloom, Smoothed orientational order
proﬁle of lipid bilayers by 2H-nuclear magnetic resonance, Biophys. J. 56 (1989)
1037–1041.
[53] H.I. Petrache, S.W. Dodd, M.F. Brown, Area per lipid and acyl length distributions in
ﬂuid phosphatidylcholines determined by 2H NMR spectroscopy, Biophys. J. 79
(2000) 3172–3192.
[54] A. Vogel, C.P. Katzka, H. Waldmann, K. Arnold, M.F. Brown, D. Huster, Lipid
modiﬁcations of a ras peptide exhibit altered packing and mobility versus host
membrane as detected by 2H solid-state NMR, J. Am. Chem. Soc. 127 (2005)
12263–12272.[55] M.F. Brown, Theory of spin-lattice relaxation in lipid bilayers and biological
membranes. 2H and 14N quadrupolar relaxation, J. Chem. Phys. 77 (1982)
1576–1799.
[56] Y.J. Wang, O. Jardetzky, Probability-based protein secondary structure
identiﬁcation using combined NMR chemical-shift data, Protein Sci. 11
(2002) 852–861.
[57] S. Luca, D.V. Filippov, J.H. van Boom, H. Oschkinat, H.J. de Groot, M. Baldus,
Secondary chemical shifts in immobilized peptides and proteins: a qualitative
basis for structure reﬁnement under magic angle spinning, J. Biomol. NMR 20
(2001) 325–331.
[58] http://www.bmrb.wisc.edu/index.html.
[59] D. Murray, N. Ben-Tal, B. Honig, S. McLaughlin, Electrostatic interaction of
myristoylated proteins with membranes: simple physics, complicated biology,
Structure 5 (1997) 985–989.
[60] S.H. White, W.C. Wimley, Membrane protein folding and stability: physical
principles, Annu. Rev. Biophys. Biomol. Struct. 28 (1999) 319–365.
[61] G. Reuther, K.T. Tan, A. Vogel, C. Nowak, J. Kuhlmann, H. Waldmann, D. Huster, The
lipidated membrane anchor of the N-ras protein shows an extensive dynamics as
revealed by solid-state NMR, J. Am. Chem. Soc. 128 (2006) 13840–13846.
[62] C. Tanford, The Hydrophobic Effect: Formation of Micelles and Biological
Membranes, John Wiley and Sons, New York, 1980.
